ATNM, ASE
Actinium Pharmaceuticals, Inc. (ATNM)
Price (as of October 26)
7.92USD
Correlations
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
CorMedix Inc. |
-0.34 |
|
iBio, Inc. |
-0.31 |
|
CEL-SCI Corporation |
-0.31 |
|
HOOKIPA Pharma Inc. |
-0.31 |
|
Ikena Oncology, Inc. |
-0.31 |
|
Editas Medicine, Inc. |
0 |
|
Crinetics Pharmaceuticals, Inc. |
-0.03 |
|
AgeX Therapeutics, Inc. |
-0.03 |
|
Epizyme, Inc. |
-0.01 |
|
Harpoon Therapeutics, Inc. |
0 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arcturus Therapeutics Holdings Inc. |
0.55 |
|
Ascendis Pharma A/S |
0.52 |
|
Arrowhead Pharmaceuticals, Inc. |
0.52 |
|
Arvinas, Inc. |
0.46 |
|
Atai Life Sciences N.V. |
0.45 |
|
Ardelyx, Inc. |
0.1 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Fortress Biotech, Inc. |
0.02 |
|
Alnylam Pharmaceuticals, Inc. |
0.03 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Arbutus Biopharma Corporation |
-0.17 |
|
AC Immune SA |
-0.16 |
|
AIkido Pharma Inc. |
-0.12 |
|
ImmunityBio, Inc. |
-0.11 |
|
Harpoon Therapeutics, Inc. |
-0.11 |
|
iBio, Inc. |
-0 |
|
Acasti Pharma Inc. |
0.04 |
|
Akouos, Inc. |
-0.05 |
|
Achilles Therapeutics plc |
-0.1 |
|
ERYTECH Pharma S.A. |
0.02 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.5 |
|
Arcutis Biotherapeutics, Inc. |
0.49 |
|
Arcturus Therapeutics Holdings Inc. |
0.46 |
|
Ascendis Pharma A/S |
0.4 |
|
Aravive, Inc. |
0.4 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Artelo Biosciences, Inc. |
0.09 |
|
argenx SE |
0.11 |
|
Arvinas, Inc. |
0.17 |
|
Atai Life Sciences N.V. |
0.28 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Ambrx Biopharma Inc. |
-0.12 |
|
Imago BioSciences, Inc. |
-0.11 |
|
Achilles Therapeutics plc |
-0.1 |
|
Addex Therapeutics Ltd |
-0.1 |
|
DICE Therapeutics, Inc. |
-0.09 |
|
Biomea Fusion, Inc. |
-0.08 |
|
Aerovate Therapeutics, Inc. |
-0.08 |
|
CinCor Pharma, Inc. |
-0.08 |
|
Humacyte, Inc. |
-0.07 |
|
Genprex, Inc. |
-0.06 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.28 |
|
Arcturus Therapeutics Holdings Inc. |
0.23 |
|
Aprea Therapeutics, Inc. |
0.21 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Ascendis Pharma A/S |
0.19 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Arvinas, Inc. |
0.17 |
|
Arrowhead Pharmaceuticals, Inc. |
0.09 |
|
argenx SE |
0.11 |
|
Athira Pharma, Inc. |
0.12 |
Lowest within Industry
| Symbol | Correlation |
|---|---|
|
Ambrx Biopharma Inc. |
-0.12 |
|
Imago BioSciences, Inc. |
-0.11 |
|
Achilles Therapeutics plc |
-0.1 |
|
Addex Therapeutics Ltd |
-0.1 |
|
DICE Therapeutics, Inc. |
-0.09 |
|
Biomea Fusion, Inc. |
-0.08 |
|
Aerovate Therapeutics, Inc. |
-0.08 |
|
CinCor Pharma, Inc. |
-0.08 |
|
Humacyte, Inc. |
-0.07 |
|
BioLineRx Ltd. |
-0.06 |
Highest within Industry
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.28 |
|
Aprea Therapeutics, Inc. |
0.21 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Arcturus Therapeutics Holdings Inc. |
0.18 |
|
Arvinas, Inc. |
0.17 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Ascendis Pharma A/S |
0.14 |
|
Athira Pharma, Inc. |
0.12 |
|
ASLAN Pharmaceuticals Limited |
0.12 |
|
BioNTech SE |
0.11 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Elanco Animal Health Incorporated |
-0.4 |
|
CorMedix Inc. |
-0.34 |
|
iBio, Inc. |
-0.31 |
|
CEL-SCI Corporation |
-0.31 |
|
HOOKIPA Pharma Inc. |
-0.31 |
|
Ikena Oncology, Inc. |
-0.05 |
|
Global Cord Blood Corporation |
-0.04 |
|
Editas Medicine, Inc. |
0 |
|
Crinetics Pharmaceuticals, Inc. |
-0.03 |
|
Bio-Rad Laboratories, Inc. |
0 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arcturus Therapeutics Holdings Inc. |
0.55 |
|
Ascendis Pharma A/S |
0.52 |
|
Arrowhead Pharmaceuticals, Inc. |
0.52 |
|
Arvinas, Inc. |
0.46 |
|
Atai Life Sciences N.V. |
0.45 |
|
Ardelyx, Inc. |
0.1 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Aquestive Therapeutics, Inc. |
0.14 |
|
ATI Physical Therapy, Inc. |
0.17 |
|
Atara Biotherapeutics, Inc. |
0.16 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
Arbutus Biopharma Corporation |
-0.17 |
|
AC Immune SA |
-0.16 |
|
DocGo Inc. |
-0.16 |
|
Accolade, Inc. |
-0.15 |
|
Elanco Animal Health Incorporated |
-0.15 |
|
Alvotech |
-0.14 |
|
Eagle Pharmaceuticals, Inc. |
0.01 |
|
AcelRx Pharmaceuticals, Inc. |
0.03 |
|
Global Cord Blood Corporation |
-0.04 |
|
AIkido Pharma Inc. |
-0 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Arrowhead Pharmaceuticals, Inc. |
0.5 |
|
Arcutis Biotherapeutics, Inc. |
0.49 |
|
Arcturus Therapeutics Holdings Inc. |
0.46 |
|
Asensus Surgical, Inc. |
0.41 |
|
Ascendis Pharma A/S |
0.4 |
|
Aravive, Inc. |
0.03 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Aquestive Therapeutics, Inc. |
0.14 |
|
Alphatec Holdings, Inc. |
0.05 |
|
Artelo Biosciences, Inc. |
0.09 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
DocGo Inc. |
-0.16 |
|
Alvotech |
-0.14 |
|
Ambrx Biopharma Inc. |
-0.12 |
|
Imago BioSciences, Inc. |
-0.11 |
|
Achilles Therapeutics plc |
-0.1 |
|
Addex Therapeutics Ltd |
-0.1 |
|
DICE Therapeutics, Inc. |
-0.09 |
|
Acutus Medical, Inc. |
-0.09 |
|
Biomea Fusion, Inc. |
-0.08 |
|
Aerovate Therapeutics, Inc. |
-0.08 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.28 |
|
Arcturus Therapeutics Holdings Inc. |
0.23 |
|
Aprea Therapeutics, Inc. |
0.21 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Ascendis Pharma A/S |
0.19 |
|
ATI Physical Therapy, Inc. |
0.17 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
Arvinas, Inc. |
0.17 |
|
Arrowhead Pharmaceuticals, Inc. |
0.09 |
|
HeartBeam, Inc. |
0.15 |
Lowest by Sector
| Symbol | Correlation |
|---|---|
|
DocGo Inc. |
-0.16 |
|
Alvotech |
-0.14 |
|
Ambrx Biopharma Inc. |
-0.12 |
|
Imago BioSciences, Inc. |
-0.11 |
|
Achilles Therapeutics plc |
-0.1 |
|
Addex Therapeutics Ltd |
-0.1 |
|
DICE Therapeutics, Inc. |
-0.09 |
|
Acutus Medical, Inc. |
-0.09 |
|
Biomea Fusion, Inc. |
-0.08 |
|
Aerovate Therapeutics, Inc. |
-0.08 |
Highest by Sector
| Symbol | Correlation |
|---|---|
|
Atai Life Sciences N.V. |
0.28 |
|
Aprea Therapeutics, Inc. |
0.21 |
|
Arcutis Biotherapeutics, Inc. |
0.19 |
|
Arcturus Therapeutics Holdings Inc. |
0.18 |
|
ATI Physical Therapy, Inc. |
0.17 |
|
Arvinas, Inc. |
0.17 |
|
Atara Biotherapeutics, Inc. |
0.16 |
|
HeartBeam, Inc. |
0.15 |
|
Ascendis Pharma A/S |
0.14 |
|
Aquestive Therapeutics, Inc. |
0.14 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
iShares MSCI Denmark ETF |
-0.42 |
|
Ault Disruptive Technologies Corporation |
-0.41 |
|
Elanco Animal Health Incorporated |
-0.4 |
|
Canadian Solar Inc. |
-0.37 |
|
CRH plc |
-0.36 |
|
DatChat, Inc. |
-0.05 |
|
Concord Acquisition Corp II |
-0.15 |
|
Excelerate Energy, Inc. |
-0.31 |
|
eMagin Corporation |
-0.02 |
|
CorMedix Inc. |
-0.01 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
Arcturus Therapeutics Holdings Inc. |
0.55 |
|
First Trust IndxxMetaverse ETF |
0.53 |
|
ARK Genomic Revolution ETF |
0.53 |
|
Ascendis Pharma A/S |
0.52 |
|
Arrowhead Pharmaceuticals, Inc. |
0.52 |
|
Sendas Distribuidora S.A. |
0.24 |
|
ARK Autonomous Technology & Robotics ETF |
0.23 |
|
ARK Space Exploration & Innovation ETF |
0.43 |
|
Arvinas, Inc. |
0.17 |
|
Astra Space Operations, Inc. |
0.24 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Excelerate Energy, Inc. |
-0.31 |
|
Catalyst Bancorp, Inc. |
-0.24 |
|
A SPAC II Acquisition Corporation |
-0.23 |
|
General Electric Company |
-0.21 |
|
Blockchain Moon Acquisition Corp. |
-0.21 |
|
First Trust S-Network Streaming and Gaming ETF |
-0.2 |
|
Mesa Air Group, Inc. |
0.02 |
|
Consilium Acquisition Corp I, Ltd. |
-0.19 |
|
AltEnergy Acquisition Corp. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
ARK Genomic Revolution ETF |
0.54 |
|
First Trust IndxxMetaverse ETF |
0.53 |
|
Arrowhead Pharmaceuticals, Inc. |
0.5 |
|
Arcutis Biotherapeutics, Inc. |
0.49 |
|
ARK Autonomous Technology & Robotics ETF |
0.47 |
|
ARK Space Exploration & Innovation ETF |
0.43 |
|
Arcturus Therapeutics Holdings Inc. |
0.18 |
|
ALGER 35 ETF |
0.38 |
|
Asensus Surgical, Inc. |
0.1 |
|
Aqua Metals, Inc. |
0.15 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Excelerate Energy, Inc. |
-0.31 |
|
Catalyst Bancorp, Inc. |
-0.24 |
|
A SPAC II Acquisition Corporation |
-0.23 |
|
Blockchain Moon Acquisition Corp. |
-0.21 |
|
First Trust S-Network Streaming and Gaming ETF |
-0.2 |
|
Consilium Acquisition Corp I, Ltd. |
-0.19 |
|
AltEnergy Acquisition Corp. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
|
Fortune Rise Acquisition Corporation |
-0.17 |
|
Galata Acquisition Corp. |
-0.16 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
First Trust IndxxMetaverse ETF |
0.53 |
|
ARK Space Exploration & Innovation ETF |
0.43 |
|
AI Quality Growth ETF |
0.39 |
|
ALGER 35 ETF |
0.38 |
|
Arrival |
0.35 |
|
Argo Blockchain plc |
0.32 |
|
Arhaus, Inc. |
0.3 |
|
Atai Life Sciences N.V. |
0.28 |
|
Fidelity Metaverse ETF |
0.26 |
|
ARK Genomic Revolution ETF |
0.26 |
Lowest Overall
| Symbol | Correlation |
|---|---|
|
Excelerate Energy, Inc. |
-0.31 |
|
Catalyst Bancorp, Inc. |
-0.24 |
|
A SPAC II Acquisition Corporation |
-0.23 |
|
Blockchain Moon Acquisition Corp. |
-0.21 |
|
First Trust S-Network Streaming and Gaming ETF |
-0.2 |
|
Consilium Acquisition Corp I, Ltd. |
-0.19 |
|
AltEnergy Acquisition Corp. |
-0.18 |
|
Optica Rare Earths & Critical Materials ETF |
-0.18 |
|
Fortune Rise Acquisition Corporation |
-0.17 |
|
Galata Acquisition Corp. |
-0.16 |
Highest Overall
| Symbol | Correlation |
|---|---|
|
First Trust IndxxMetaverse ETF |
0.53 |
|
ARK Space Exploration & Innovation ETF |
0.43 |
|
AI Quality Growth ETF |
0.39 |
|
ALGER 35 ETF |
0.38 |
|
Arrival |
0.35 |
|
Argo Blockchain plc |
0.32 |
|
Arhaus, Inc. |
0.3 |
|
Atai Life Sciences N.V. |
0.28 |
|
Fidelity Metaverse ETF |
0.26 |
|
ARK Genomic Revolution ETF |
0.26 |
Profile
- Sector:
- Healthcare
- Industry:
- Biotechnology
Actinium Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing therapies for bone marrow transplant (BMT) or a type of cellular therapy, and for other adoptive cell therapies. Its lead product candidate, I-131 apamistamab (Iomab-B) that is in a pivotal Phase III clinical trial for elderly relapsed or refractory acute myeloid leukemia trial for BMT conditioning; and a Phase I study with a CD19- targeted CAR T-cell therapy with memorial sloan kettering cancer center. The company also offers clinical and preclinical development programs that utilize multiple isotopes, including Actinium-225, Iodine-131, and Lutetium-177 directed at multiple validated cancer targets, including CD45, CD33, CD38, CD47, HER2, and HER3 for targeted conditioning prior to cell and gene therapies, such as bone marrow transplant and cancer therapeutics as single agents or in combination with other therapeutic modalities. It has collaboration with Astellas Pharma, Inc. to develop theranostics for solid tumor indications; EpicentRx, Inc that focuses on a novel CD47 immunotherapy targeted radiotherapy; and AVEO Oncology that focuses on developing a HER3 targeting ARC for solid tumors. The company was incorporated in 2000 and is based in New York, New York.